HomeITRM • NASDAQ
add
Iterum Therapeutics PLC
Previous close
$0.47
Day range
$0.46 - $0.50
Year range
$0.36 - $3.02
Market cap
24.28M USD
Avg Volume
1.14M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 390.00K | — |
Operating expense | 8.10M | 65.77% |
Net income | -8.98M | -47.34% |
Net profit margin | -2.30K | — |
Earnings per share | — | — |
EBITDA | -7.38M | -51.18% |
Effective tax rate | -1.49% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.00M | -24.13% |
Total assets | 32.50M | 104.11% |
Total liabilities | 39.88M | 45.40% |
Total equity | -7.38M | — |
Shares outstanding | 52.79M | — |
Price to book | -3.13 | — |
Return on assets | -58.11% | — |
Return on capital | -70.25% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -8.98M | -47.34% |
Cash from operations | -7.45M | -178.71% |
Cash from investing | -12.00K | -100.21% |
Cash from financing | 5.43M | 0.04% |
Net change in cash | -2.03M | -124.07% |
Free cash flow | -4.84M | -590.53% |
About
Founded
2015
Website
Employees
9
